Mike Baker’s Appearance on The Joe Rogan Experience

Mike Baker’s Appearance on The Joe Rogan Experience

On September 6, 2022, Mike Baker, a Pulitzer Prize-winning investigative journalist, appeared on The Joe Rogan Experience podcast. The two-hour conversation covered a wide range of topics, including Baker’s work on the opioid crisis, the Sackler family, and the pharmaceutical industry.

Baker began by discussing his reporting on the opioid crisis. He described how the crisis began in the late 1990s with the introduction of OxyContin, a powerful opioid painkiller. Baker said that Purdue Pharma, the manufacturer of OxyContin, aggressively marketed the drug to doctors, who then prescribed it to patients for a variety of conditions, including pain from minor injuries.

Baker said that Purdue Pharma knew that OxyContin was addictive, but they continued to market the drug aggressively. He also said that the company paid doctors to promote OxyContin and gave kickbacks to pharmacies that sold the drug.

As a result of Purdue Pharma’s actions, millions of Americans became addicted to opioids. The crisis has led to hundreds of thousands of deaths and has devastated communities across the country.

Baker also discussed the Sackler family, the owners of Purdue Pharma. He said that the Sacklers knew about the dangers of OxyContin, but they continued to make billions of dollars from the drug. Baker said that the Sacklers are “responsible for the opioid crisis.”

In addition to the opioid crisis, Baker and Rogan also discussed the pharmaceutical industry as a whole. Baker said that the pharmaceutical industry is “corrupt” and that it puts profits ahead of patients.

Baker said that the pharmaceutical industry spends billions of dollars on lobbying and campaign contributions. He also said that the industry uses its influence to prevent the government from regulating the industry more effectively.

Baker and Rogan’s conversation was wide-ranging and informative. Baker provided important insights into the opioid crisis and the pharmaceutical industry. The conversation is a must-listen for anyone who wants to understand these important issues.